Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Net (2013 - 2024)

Viridian Therapeutics, Inc.\DE's Receivables - Net history runs 12 years deep, the most recent figure standing at $14000.0 for Q3 2024.

• In Q3 2024, Receivables - Net fell 86.27% year-over-year to $14000.0; the TTM figure through Sep 2024 stood at $14000.0 (down 86.27% YoY), while the FY2023 annual figure was $102000.0, changed 0.0% from the prior year.
• Receivables - Net for Q3 2024 stood at $14000.0, down from $102000.0 in the prior quarter.
• The five-year high for Receivables - Net was $1.0 million in Q3 2021, with the low at $4000.0 in Q1 2020.
• The 5-year median for Receivables - Net is $102000.0 (2022), against an average of $268333.3.
• The sharpest annual moves came in 2020 and 2021: Receivables - Net slumped 94.18% in 2020, then jumped 1654.39% in 2021.
• Viridian Therapeutics, Inc.\DE's Receivables - Net stood at $57000.0 in 2020, then surged by 691.23% to $451000.0 in 2021, then tumbled by 77.38% to $102000.0 in 2022, then changed by 0.0% to $102000.0 in 2023, then plunged by 86.27% to $14000.0 in 2024.
• Business Quant data shows VRDN's Receivables - Net at $14000.0 in Q3 2024, $102000.0 in Q1 2024, and $102000.0 in Q4 2023.